Skip to main content
SpringerLink
Log in

Role of portal vein embolization in liver surgery: single centre experience in sixty-two patients

  • Original Article
  • Published:
Updates in Surgery Aims and scope Submit manuscript

Abstract

The extent of liver resection is limited by the residual functional reserve of the liver (FLR). The introduction of portal vein embolization (PVE), with the rationale of inducing hypertrophy of the FLR has significantly reduced morbidity and in particular the impact of postoperative liver failure (PLF). The objective of the study is to evaluate the feasibility and effectiveness of PVE in patients candidates to liver resections with high risk of PLF. Between January 2006 and December 2009, 62 patients suffering from primary or metastatic liver tumour, underwent PVE at the Department of Surgery–Liver Unit HSR. CT assessment of hepatic volume was performed in each patient, prior and 4 weeks after the procedure. The outcome was evaluated in terms of feasibility of surgery, FLR growth [calculated as: (FLR after PVE − FLR pre PVE) × 100/FLR pre PVE], morbidity and mortality associated with PVE and surgery. Of the 62 patients undergoing PVE, 6 (9.7%) did not benefit from surgery: of these, 4 showed spread of disease in the FLR at CT control, while in the remaining 2 adequate hypertrophy was not reached. The average volume of the FLR at the time of the procedure and after 4 weeks was 437.03 cc (±172.54) and 615.15 cc (± 187.49), respectively, with an average increase of 50.3% (±30.31). During the postoperative period, only 2 patients (3.2%) showed mild and transient signs of the PLF. The technique of PVE allows to performing, in an effective and safe way, major liver resections in patients with high risk of PLF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Belghiti J, Hiramatsu K, Benoist S et al (2000) Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 191:38–46

    Article  CAS  PubMed  Google Scholar 

  2. Jarnagin WR, Gonen M, Fong Y et al (2002) Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 236:397–407

    Article  PubMed  Google Scholar 

  3. Fong Y, Fortner J, Sun RL et al (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230:309–321

    Article  CAS  PubMed  Google Scholar 

  4. Arru M, Aldrighetti L, Castoldi R, Di Palo S, Orsenigo E, Stella M, Pulitanò C, Gavazzi F, Ferla G, Di Carlo V, Staudacher C (2008) Analysis of prognostic factors influencing long-term survival after hepatic resection for metastatic colorectal cancer. World J Surg 32:93–103

    Article  PubMed  Google Scholar 

  5. Melendez J, Ferri E, Zwillman M et al (2001) Extended hepatic resection: a 6-year retrospective study of risk factors for perioperative mortality. J Am Coll Surg 192:47–53

    Article  CAS  PubMed  Google Scholar 

  6. Shirabe K, Shimada M, Gion T et al (1999) Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg 188:304–309

    Article  CAS  PubMed  Google Scholar 

  7. Capussotti L, Viganò L, Giuliante F, Ferrero A, Giovannini I, Nuzzo G (2009) Liver dysfunction and sepsis determine operative mortality after liver resection. Br J Surg 96:88–94

    Article  CAS  PubMed  Google Scholar 

  8. Kinoshita H, Sakai K, Hirohashi K et al (1986) Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg 10:803–808

    Article  CAS  PubMed  Google Scholar 

  9. Makuuchi M, Thai BL, Takayasu K et al (1990) Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 107:521–527

    CAS  PubMed  Google Scholar 

  10. Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213

    Article  PubMed  Google Scholar 

  11. Balzan S, Belghiti J et al (2005) The “50-50 Criteria” on postoperative day 5. Ann Surg 242:824–829

    Article  PubMed  Google Scholar 

  12. de Baere T, Roche A, Elias D, Lasser P, Lagrange C, Bousson V (1996) Preoperative portal vein embolization for extension of hepatectomy indications. Hepatology 24:1386–1391

    Article  PubMed  Google Scholar 

  13. Di Stefano DR, de Baere T, Denys A et al (2005) Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients. Radiology 234:625–630

    Article  PubMed  Google Scholar 

  14. Nagino M, Nimura Y, Kamiya J, Kondo S, Kanai M (1996) Selective percutaneous transhepatic embolization of the portal vein in preparation for extensive liver resection: the ipsilateral approach. Radiology 200:559–563

    CAS  PubMed  Google Scholar 

  15. Denys A, Madoff DC, Doenz F, Schneider F, Gillet M, Vauthey JN, Chevallier P (2002) Indications for and limitations of portal vein embolization before major hepatic resection for hepatobiliary malignancy. Surg Oncol Clin N Am 11:955–968

    Article  PubMed  Google Scholar 

  16. Kishi Y, Zorzi D, Contreras CM, Maru DM, Kopetz S, Ribero D, Motta M, Ravarino N, Risio M, Curley SA, Abdalla EK, Capussotti L, Vauthey JN (2010) Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases. Ann Surg Oncol 17:2870–2876

    Article  PubMed  Google Scholar 

  17. Nuzzo G, Giuliante F, Ardito F, Vellone M, Pozzo C, Cassano A, Giovannini I, Barone C (2007) Liver resection for primarily unresectable colorectal metastases downsized by chemotherapy. J Gastrointest Surg 11:318–324

    Article  PubMed  Google Scholar 

  18. Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM, Xiong HQ, Eng C, Lauwers GY, Mino-Kenudson M, Risio M, Muratore A, Capussotti L, Curley S, Abdalla E (2006) Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24:2065–2072

    Article  CAS  PubMed  Google Scholar 

  19. Ferrero A, Vigano L, Polastri R, Muratore A, Eminefendic H, Regge D, Capussotti L (2007) Postoperative liver dysfunction and future remnant liver: where is the limit? Results of a prospective study. World J Surg 31:1643–1651

    Article  PubMed  Google Scholar 

  20. Abdalla EK, Hicks ME, Vauthey JN (2001) Portal vein embolization: rationale, technique and future prospects. Br J Surg 88:165–175

    Article  CAS  PubMed  Google Scholar 

  21. Kubota K, Makuuchi M, Kusaka K et al (1997) Measurement of liver volume and hepatic functional reserve as guide to decision-making in resectional surgery for hepatic tumors. Hepatology 26:1176–1181

    CAS  PubMed  Google Scholar 

  22. Vauthey JN, Chaoui A, Do KA et al (2000) Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 127:512–519

    Article  CAS  PubMed  Google Scholar 

  23. Azoulay D, Castaing D, Krissat J et al (2000) Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg 232:665–672

    Article  CAS  PubMed  Google Scholar 

  24. Madoff DC, Hicks ME, Vauthey JN et al (2002) Transhepatic portal vein embolization: anatomy, indications, and technical considerations. RadioGraphics 22:1063–1076

    PubMed  Google Scholar 

  25. Makuuchi M, Kosuge T, Lygidakis NJ (1991) New possibilities for major liver surgery in patients with Klatskin tumors or primary hepatocellular carcinoma: an old problem revisited. Hepatogastroenterology 38:329–336

    CAS  PubMed  Google Scholar 

  26. Nagino H, Nimura Y, Kamiya J, Kondo S, Uesaka K, Kin Y (1995) Changes in hepatic lobe volume in biliary tract carcinoma patients after portal vein embolization. Hepatology 21:434–439

    CAS  PubMed  Google Scholar 

  27. Abulkhir A, Limongelli P, Healey AJ, Damrah O, Tait P, Jackson J, Habib N, Jiao L (2008) Preoperative portal vein embolization for major liver resection. A meta-analysis. Ann Surg 247:49–57

    Article  PubMed  Google Scholar 

  28. De Baere T, teriitehau C, Deschamps F, Catherine L, Rao P, Hakime A, Auperine A, Goere D, Elias D, Hechelhammer L (2010) Predictive factors for hypertrophy of the future remnant liver after selective portal vein embolization. Ann Surg Oncol 17:2081–2089

    Article  PubMed  Google Scholar 

  29. Herrera MC, Palomero MF, Macias RI, Serrano MA, Marin JJ (1998) Comparison of the effects of bischolylglycinatechloro-platinum (II) versus cisplatin on liver regeneration after partial hepatectomy. Anticancer Res 18:3555–3563

    CAS  PubMed  Google Scholar 

  30. Goere D, Farges O, Leporrier J, Sauvanet A, Vilgrain V, Belghiti J (2006) Chemotherapy does not impair hypertrophy of the left liver after right portal vein obstruction. J Gastrointest Surg 10:365–370

    Article  PubMed  Google Scholar 

  31. Tanaka K, Kumamoto T, Matsuyama R, Takeda K, Nagano Y, Endo I (2010) Influence of chemotherapy on liver regeneration induced by portal vein embolization or first hepatectomy of a staged procedure for colorectal liver metastases. J Gastrointest Surg 14:359–368

    Article  PubMed  Google Scholar 

  32. Joseph S, Connor S, Garden OJ (2008) Staging laparoscopy for cholangiocarcinoma. HPB 10:116–119

    Article  CAS  PubMed  Google Scholar 

  33. Kianmanesh R, Farges O, Abdalla EK, Sauvanet A, Ruszniewski P, Belghiti J (2003) Right portal vein ligation: a new planned two-step all-surgical approach for complete resection of primary gastrointestinal tumors with multiple bilateral liver metastases. J Am Coll Surg 197(1):164–170

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Dipartimento di Chirurgia Generale e Specialistica, Unità Operativa Complessa Chirurgia Epatobiliare, Liver Unit, IRCCS H San Raffaele, Università Vita-Salute S. Raffaele, Via Olgettina 60, 20132, Milan, Italy

    Francesca Ratti, Marco Catena, Michele Paganelli, Gianfranco Ferla & Luca Aldrighetti

  2. Unità di Radiologia Diagnostica e Interventistica, IRCCS H San Raffaele, Università Vita-Salute S.Raffaele, Via Olgettina 60, 20132, Milan, Italy

    Corrado Soldati

Authors
  1. Francesca Ratti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Corrado Soldati
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marco Catena
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michele Paganelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gianfranco Ferla
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Luca Aldrighetti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Francesca Ratti.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ratti, F., Soldati, C., Catena, M. et al. Role of portal vein embolization in liver surgery: single centre experience in sixty-two patients. Updates Surg 62, 153–159 (2010). https://doi.org/10.1007/s13304-010-0033-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13304-010-0033-8

Keywords

Search

Navigation